Development asset linked to Univar Solutions in public FDA and regional records.
pharma · Wilson’s Disease
Univar Solutions
Univar Solutions BV
Univar Solutions drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Downers Grove, USA HQ
1924 Founded
9,223 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Downers Grove, USA
- Founded
- 1924
- Employees
- 9,223
- Programs
- 1
- Drugs
- 3
- Patents
- 0
Univar Solutions pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Univar Solutions drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Univar Solutions in public FDA and regional records.
-
trientine dihydrochloride
Alimentary tract and metabolism (A16)Alimentary tract and metabolism (A16) compound in Univar Solutions's portfolio. Molecular target: Copper.
- Target
- Copper
- Mechanism
- Copper chelating agent